Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
VNRX

VNRX - VolitionRX Ltd Stock Price, Fair Value and News

$0.26-0.01 (-3.70%)
Market Closed

6/100

VNRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

6/100

VNRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.22

Target 3M

$0.25

Target 6M

$0.24

VNRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VNRX Price Action

Last 7 days

-10.3%

Last 30 days

8.3%

Last 90 days

-40.9%

Trailing 12 Months

-58.1%

VNRX RSI Chart

VNRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VNRX Valuation

Market Cap

31.9M

Price/Earnings (Trailing)

-1.38

Price/Sales (Trailing)

21.69

Price/Free Cashflow

-1.61

VNRX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.22

Target 3M

$0.25

Target 6M

$0.24

VNRX Fundamentals

VNRX Revenue

Revenue (TTM)

1.5M

Rev. Growth (Yr)

32.19%

Rev. Growth (Qtr)

54.24%

VNRX Earnings

Earnings (TTM)

-23.2M

Earnings Growth (Yr)

7.61%

Earnings Growth (Qtr)

14.82%

VNRX Profitability

Return on Equity

64.43%

Return on Assets

-359.18%

Free Cashflow Yield

-61.93%

VNRX Investor Care

Shares Dilution (1Y)

32.52%

Diluted EPS (TTM)

-0.23

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.3M1.3M1.5M0
2024797.0K976.5K1.3M1.2M
20231.3M1.1M1.1M775.3K
20221.6M1.6M1.4M1.3M
2021880.1K1.1M1.3M1.5M
2020193.4K284.4K267.3K666.0K
20190031.9K169.8K
20140054.1K42.4K
2012197.3K191.0K197.5K55.0K
2011000208.1K
20100000
Get all data in R, Python etc through our Historical Stock Data APIs

About VolitionRX Ltd

VNRX
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company is based in Henderson, Nevada.
 CEO
 WEBSITEhttps://volition.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES111

VolitionRX Ltd Frequently Asked Questions

VNRX is the stock ticker symbol of VolitionRX Ltd. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of VolitionRX Ltd is 31.93 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check VNRX's fair value in chart for subscribers.

The fair value guage provides a quick view whether VNRX is over valued or under valued. Whether VolitionRX Ltd is cheap or expensive depends on the assumptions which impact VolitionRX Ltd's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VNRX.

As of Wed Jan 28 2026, VNRX's PE ratio (Price to Earnings) is -1.38 and Price to Sales (PS) ratio is 21.69. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VNRX PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, VolitionRX Ltd has provided -0.235 (multiply by 100 for percentage) rate of return.